Redmile Group’s Carisma Therapeutics CARM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2016
Q1
Sell
-43,793
Closed -$2.64M 49
2015
Q4
$2.64M Buy
43,793
+1,375
+3% +$82.8K 0.2% 43
2015
Q3
$2.05M Sell
42,418
-20,645
-33% -$995K 0.15% 47
2015
Q2
$3.56M Buy
63,063
+51,063
+426% +$2.88M 0.29% 48
2015
Q1
$2.14M Hold
12,000
0.19% 49
2014
Q4
$2.85M Buy
+12,000
New +$2.85M 0.31% 42